Please provide your email address to receive an email when new articles are posted on . CHICAGO — Implementation of an endocrinology fast-track program may allow patients with poorly controlled ...

Modified FOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab beyond first progression in advanced colorectal cancer: CCOG-0801 study. A phase I/II study of biweekly XELIRI plus bevacizumab ...

Researchers recently examined more than 1500 knee and hip replacement procedures conducted as part of a single institution’s fast-track protocol. At 1 year, patients in the fast-track program reported ...

Abenacianine, a fluorescent imaging agent, aids in real-time tumor visualization during lung cancer surgeries, enhancing surgical precision and outcomes. Fast track designation by the FDA highlights ...

Adaptations to a program that helps ensure the best possible outcomes from surgery allowed eligible patients to receive their hip and knee replacement surgeries during the COVID-19 pandemic without ...

The Fast Track designation is supported by the ongoing randomized, double-masked phase 3 LYNX-2 trial. The Food and Drug Administration (FDA) has granted Fast Track designation to phentolamine ...

MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that the U.S. Food & Drug Administration (FDA) has granted ...